Global Next Generation Sequencing Market

Next Generation Sequencing (NGS) Market Size, Share, Growth Analysis, By Product & Service (Consumables, Services, Pre-Sequencing Products), By Technology (Sequencing by Synthesis, Nanopore Sequencing), By End User (Academic Institutes and Research Centers, Pharmaceutical and Biotechnology Companies), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35D2046 | Region: Global | Published Date: August, 2024
Pages: 157 | Tables: 98 | Figures: 76

Next Generation Sequencing Market Dynamics

Drivers 

High Demand for Personalized Medicine 

  • NGS allows extensive analysis of a person’s genome, which helps in the identification of genetic variations. This influence drug response, susceptibility to diseases, and possible adverse reactions. This personalized technique is boosting the incorporation of NGS into clinical settings, where it improves treatment efficiency by customizing therapies that match the genetic profiles of patients. 

Growing Popularity of Precision Oncology 

  • In oncology, NGS plays a vital part in recognizing particular mutations within tumors. This molecular profiling allows oncologists to prescribe targeted therapies developed for addressing the unique genetic features of every patient’s cancer. Therefore, NGS contributes massively to enhancing treatment results and patient survival rates in cancer care. 

Restraints 

High Expense of NGS Processes 

  • The expense related with NGS processes, encompassing sequencing, data analysis, and interpretation, creates a huge barrier to accessibility for both patients and medical professionals. The cost related to acquiring and maintaining NGS technologies restricts its utilization in clinical settings, particularly in resource-constrained structures.  

Data Storage and Analysis 

  • NGS creates massive amounts of genomic data, developing huge difficulties for storage, management, analysis, and interpretation. Effective data management solutions that are scalable, secure, and cost-efficient are vital for managing such huge datasets generated by NGS platforms. Developments in bioinformatics tools and cloud computing technologies are vital in facilitating robust data analysis pipelines. This is also allowing researchers and clinicians to extract valuable insights from genomic information. 
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Next Generation Sequencing Market size was valued at USD 7.82 billion in 2022 and is poised to grow from USD 9.27 billion in 2023 to USD 36.04 billion by 2031, growing at a CAGR of 18.5% in the forecast period (2024-2031). 

The next-generation sequencing market can be defined by intense competition among the prominent market players. The introduction of unique platforms that are fast, small, and affordable is one of the tactics utilized by the organizations to enhance their market position. Cerba Research, declared two new COVID-19 exploratory tools in January 2021, one PCR-based and the NGS-based for improving research and development necessary for vaccine development against coronavirus.  'Illumina Inc. (US)  ', 'Thermo Fisher Scientific, Inc. (US)  ', 'PerkinElmer Inc. (US)  ', 'BGI Group (China)  ', 'Agilent Technologies Inc. (US)  ', 'Eurofins Scientific SE (Luxembourg)  ', 'Pacific Biosciences of California Inc. (US)  ', 'Oxford Nanopore Technologies (UK)  ', 'QIAGEN NV (Netherlands)  ', 'F. Hoffmann-La Roche AG (Switzerland)  ', 'GENEWIZ Inc. (US)  ', 'Psomagen, Inc. (South Korea)  ', '10x Genomics Inc. (US) '

NGS allows extensive analysis of a person’s genome, which helps in the identification of genetic variations. This influence drug response, susceptibility to diseases, and possible adverse reactions. This personalized technique is boosting the incorporation of NGS into clinical settings, where it improves treatment efficiency by customizing therapies that match the genetic profiles of patients. 

NGS provides a powerful tool for diagnosing rare genetic disorders accurately and swiftly. By sequencing an individual’s genome, clinicians can pinpoint the genetic basis of rare diseases, enabling early intervention and more effective management strategies. This capability drives market growth as healthcare providers increasingly rely on NGS for precise and timely diagnosis of challenging medical conditions. 

Based on regions, North America is dominating the next generation sequencing market with the largest share. This is mainly because the region has some of the best clinical labs that use NGS for offering genetic testing services. Furthermore, increasing investment in R&D, the availability of advanced medical research structure, and the advancement of WGS is also positively influencing the market growth in this region. The presence of prominent manufacturers, active government support, and the increasing prevalence of cancer are also driving the expansion of the market in North America. The region also has many prestigious research institutions, top universities, and major pharmaceutical companies, equipped with financial resources for investing in the most advanced NGS technologies. Such infrastructure not only supports outstanding research in many scientific groups but also boosts innovation in genomic medicine and biotechnology. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Next Generation Sequencing Market

Report ID: SQMIG35D2046

$5,300
BUY NOW GET FREE SAMPLE